Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH), consisting of the first 29 amino acids of the 44-amino acid endogenous peptide. It was the first GHRH analog approved for clinical use in the United States and remains one of the most studied growth hormone secretagogues in the research literature.
Mechanism: Pituitary-Driven GH Release
Unlike direct growth hormone administration, sermorelin stimulates the pituitary gland to produce and release its own growth hormone. This mechanism preserves the natural pulsatile release pattern of GH and maintains negative feedback through somatostatin, which prevents supraphysiological GH elevations. Researchers studying age-related GH decline have used this pituitary-driven mechanism as a key point of differentiation from exogenous GH protocols.
Research in Aging Models
GH secretion declines approximately 14% per decade after age 30, a process termed somatopause. Sermorelin has been used extensively in research models examining whether restoration of youthful GH pulsatility affects body composition, bone mineral density, sleep architecture, and recovery metrics. Multiple studies in older male subjects documented increased lean mass and reduced fat mass in sermorelin-treated cohorts versus placebo.
Sleep Research
Sermorelin administration has been associated with increased slow-wave (deep) sleep in research subjects. Growth hormone secretion is predominantly nocturnal and tied to slow-wave sleep stages. The bidirectional relationship between GH and sleep quality represents an area of active investigation.
Comparison with CJC-1295
Sermorelin has a shorter half-life (approximately 10-20 minutes) compared to CJC-1295, which is modified for extended activity. This shorter duration more closely mimics the endogenous GHRH pulse pattern. CJC-1295 without DAC occupies a middle ground, while CJC-1295 with DAC produces sustained elevation. Researchers select between these depending on whether pulse mimicry or sustained elevation is the study objective.
Storage
Lyophilized sermorelin is stable at room temperature for short periods but should be stored frozen for long-term preservation. Reconstituted solution should be refrigerated and used within 30 days. Avoid vigorous agitation which can degrade the peptide.
For in vitro research use only. Not for human or veterinary use, therapeutic, or diagnostic purposes.